Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Gap Inc V.GAP


Primary Symbol: GAP

The Gap, Inc. is a specialty apparel company in America. The Company offers apparel, accessories and personal care products for women, men and children. Its Old Navy, Gap, Banana Republic, and Athleta brands offer clothing, accessories and lifestyle products for men, women and children. It is an omni-channel retailer, with sales to customers both in stores and online, through Company-operated and franchise stores, websites, and third-party arrangements. Its omni-channel services, including buying online pick-up in store, order-in-store, find-in-store, and ship-from-store, as well as enhanced mobile-enabled experiences, are tailored across its collection of brands. Gap includes adult apparel and accessories, GapKids, babyGap, Gap Maternity, GapBody, and GapFit collections. Banana Republic is a premium lifestyle retailer celebrating exploration and self-expression through timeless quality, versatile fabrics, and exceptionally made womenswear, menswear, and home designs.


NYSE:GAP - Post by User

Bullboard Posts
Comment by Laine1on Aug 20, 2009 3:30pm
210 Views
Post# 16235497

RE: Definition of 'pre-clinical'

RE: Definition of 'pre-clinical'Yes, pharmagap has always been clear about the fact that they are pure researchers. Discovering an effective compound is one small portion of drug development. Gap will hand this over the pharma at the preclinical stage.$0$0$0$0For those interested in some clarity, below is the process that happens for drug development and pharmacovigilance$0$0in Canada - international harmonization means the FDA process is similar (with a slightly shorter approval time). Pharmagap is just entering the drug discovery stage - which is no small feat. It takes the examination of almost 14,000 chemicals to find one potential drug. $0$0$0$0$0A partner will come soon enough....Gap won't license this drug. If you want to see what could potentially happen to the SP, check out Opexa (opxa) the first week in August when one of their compounds was licensed to Novartis ...it was something like .47 to 2.85 by the end of the day. $0$0$0$0$0GLTA$0$0$0Figure 117$0$0$0
Bullboard Posts